GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
07 2020
Historique:
received: 11 02 2020
accepted: 07 04 2020
pubmed: 6 6 2020
medline: 25 2 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Population mean GFR is lower in older age, but it is unknown whether healthy aging is associated with preserved rather than lower GFR in some individuals. We investigated the cross-sectional association between measured GFR, age, and health in persons aged 50-97 years in the general population through a meta-analysis of iohexol clearance measurements in three large European population-based cohorts. We defined a healthy person as having no major chronic disease or risk factors for CKD and all others as unhealthy. We used a generalized additive model to study GFR distribution by age according to health status. There were 935 (22%) GFR measurements in persons who were healthy and 3274 (78%) in persons who were unhealthy. The mean GFR was lower in older age by -0.72 ml/min per 1.73 m Healthy aging is associated with a higher mean GFR compared with unhealthy aging. However, both the mean and 97.5 percentiles of the GFR distribution are lower in older persons who are healthy than in middle-aged persons who are healthy. This suggests that healthy aging is not associated with preserved GFR in old age.

Sections du résumé

BACKGROUND
Population mean GFR is lower in older age, but it is unknown whether healthy aging is associated with preserved rather than lower GFR in some individuals.
METHODS
We investigated the cross-sectional association between measured GFR, age, and health in persons aged 50-97 years in the general population through a meta-analysis of iohexol clearance measurements in three large European population-based cohorts. We defined a healthy person as having no major chronic disease or risk factors for CKD and all others as unhealthy. We used a generalized additive model to study GFR distribution by age according to health status.
RESULTS
There were 935 (22%) GFR measurements in persons who were healthy and 3274 (78%) in persons who were unhealthy. The mean GFR was lower in older age by -0.72 ml/min per 1.73 m
CONCLUSIONS
Healthy aging is associated with a higher mean GFR compared with unhealthy aging. However, both the mean and 97.5 percentiles of the GFR distribution are lower in older persons who are healthy than in middle-aged persons who are healthy. This suggests that healthy aging is not associated with preserved GFR in old age.

Identifiants

pubmed: 32499396
pii: ASN.2020020151
doi: 10.1681/ASN.2020020151
pmc: PMC7350990
doi:

Substances chimiques

Contrast Media 0
Iohexol 4419T9MX03

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1602-1615

Subventions

Organisme : NIA NIH HHS
ID : N01AG12100
Pays : United States

Informations de copyright

Copyright © 2020 by the American Society of Nephrology.

Références

Nephrol Dial Transplant. 2010 Jun;25(6):1846-53
pubmed: 20054026
Am J Nephrol. 2015;41(1):7-15
pubmed: 25612475
Mayo Clin Proc. 1976 May;51(5):296-300
pubmed: 1263599
Am J Epidemiol. 2007 May 1;165(9):1076-87
pubmed: 17351290
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):656-60
pubmed: 23703483
Scand J Urol Nephrol. 2004;38(1):73-7
pubmed: 15204431
Kidney Int. 2010 Dec;78(12):1305-11
pubmed: 20844470
Nephron. 2015;130(4):245-55
pubmed: 26184510
J Am Soc Nephrol. 2016 Jul;27(7):2135-47
pubmed: 26701975
Kidney Int. 2004 Apr;65(4):1416-21
pubmed: 15086483
N Engl J Med. 2017 Jun 15;376(24):2349-2357
pubmed: 28614683
Clin Kidney J. 2017 Aug;10(4):545-551
pubmed: 28852494
Nephrol Dial Transplant. 2018 Aug 1;33(8):1380-1388
pubmed: 29040701
Kidney Int. 2016 Aug;90(2):404-410
pubmed: 27188503
JAMA. 2012 Dec 12;308(22):2349-60
pubmed: 23111824
Am J Kidney Dis. 2010 Aug;56(2):420-1
pubmed: 20599304
Am J Kidney Dis. 2011 Nov;58(5):764-72
pubmed: 21840098
Ann Intern Med. 2000 Oct 17;133(8):585-91
pubmed: 11033585
Hypertension. 1995 Oct;26(4):670-5
pubmed: 7558229
JAMA. 2015 Aug 11;314(6):557-8
pubmed: 26023868
J Am Geriatr Soc. 1985 Apr;33(4):278-85
pubmed: 3989190
J Am Soc Nephrol. 2019 Oct;30(10):1785-1805
pubmed: 31506289
Nephrol Dial Transplant. 2003 Oct;18(10):2047-53
pubmed: 13679479
Eur J Epidemiol. 2010 Mar;25(3):203-10
pubmed: 20094758
Nephrol Dial Transplant. 2017 Jun 1;32(6):997-1005
pubmed: 27190381
J Am Soc Nephrol. 2000 Feb;11(2):319-29
pubmed: 10665939
Clin Chem. 2008 Mar;54(3):475-81
pubmed: 18202159
PLoS One. 2015 Oct 23;10(10):e0141364
pubmed: 26495973
Kidney Int. 2006 Nov;70(10):1694-705
pubmed: 16969387
Nephrol Dial Transplant. 2012 Jul;27(7):2664-72
pubmed: 22802582
Nephron. 2017;135(2):105-119
pubmed: 27764827
Nat Rev Nephrol. 2018 Mar;14(3):151-164
pubmed: 29355169
Scand J Clin Lab Invest. 1981 Oct;41(6):611-6
pubmed: 6801756
J Am Soc Nephrol. 2019 Jan;30(1):137-146
pubmed: 30510134
Kidney Int. 2018 Sep;94(3):616-624
pubmed: 30143068
PLoS One. 2015 Jun 10;10(6):e0129036
pubmed: 26061083
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):280-6
pubmed: 26668020
Arch Intern Med. 2008 Nov 10;168(20):2212-8
pubmed: 19001197
Kidney Int. 2009 May;75(10):1079-87
pubmed: 19212414
Maturitas. 2012 Nov;73(3):230-8
pubmed: 22951150
Am J Kidney Dis. 2016 Jun;67(6):841-50
pubmed: 26744126
Nephrol Dial Transplant. 2012 Apr;27(4):1429-37
pubmed: 22076428
Scand J Clin Lab Invest. 1986 Oct;46(6):593-8
pubmed: 3095910
Nephrol Dial Transplant. 2020 Jun 1;35(6):1017-1026
pubmed: 30403810
J Am Soc Nephrol. 2011 May;22(5):927-37
pubmed: 21454717
Stat Med. 2017 Feb 28;36(5):855-875
pubmed: 27747915
Am J Kidney Dis. 2019 Jun;73(6):777-785
pubmed: 30704883
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Clin Chim Acta. 2000 Jul;297(1-2):55-66
pubmed: 10841908
Nephrol Dial Transplant. 2018 Jul 1;33(7):1176-1180
pubmed: 28992086
Nephrology (Carlton). 2008 Apr;13(2):99-103
pubmed: 18275496
Lancet. 2012 Jan 14;379(9811):165-80
pubmed: 21840587
Am J Kidney Dis. 2012 Jan;59(1):41-9
pubmed: 22000727
Nucl Med Commun. 2000 Feb;21(2):187-92
pubmed: 10758615
Kidney Int. 2018 Sep;94(3):567-581
pubmed: 30078514
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Ger Med Sci. 2016 Mar 03;14:Doc03
pubmed: 26977142
Kidney Int. 2006 Jan;69(2):375-82
pubmed: 16408129
Scand J Clin Lab Invest. 1989 Nov;49(7):641-6
pubmed: 2609107
Kidney Int. 2007 Apr;71(8):816-21
pubmed: 17332732
Kidney Int. 2006 Jun;69(12):2155-61
pubmed: 16531986
Nucl Med Commun. 2005 Jan;26(1):61-5
pubmed: 15604949
Am J Nephrol. 2008;28(4):569-75
pubmed: 18239383
Am J Kidney Dis. 2004 Jan;43(1):112-9
pubmed: 14712434
Kidney Int. 2009 Mar;75(6):652-60
pubmed: 19119287
Dtsch Arztebl Int. 2016 Mar 18;113(11):177-82
pubmed: 27118665
Nephrol Dial Transplant. 2012 May;27(5):1821-5
pubmed: 22140135
Am J Kidney Dis. 2020 Jul;76(1):54-62
pubmed: 31879216
Clin J Am Soc Nephrol. 2011 Oct;6(10):2462-9
pubmed: 21885794
J Nephrol. 2014 Dec;27(6):635-41
pubmed: 24643437
J Clin Invest. 1950 May;29(5):496-507
pubmed: 15415454
Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2186-2194
pubmed: 27683625
Hypertens Res. 2008 Mar;31(3):433-41
pubmed: 18497462
Am J Kidney Dis. 2015 Aug;66(2):240-8
pubmed: 25987258
J Am Soc Nephrol. 2011 Aug;22(8):1517-25
pubmed: 21784894
Nephrol Dial Transplant. 2008 Sep;23(9):2818-26
pubmed: 18400822
Semin Nephrol. 2009 Nov;29(6):650-7
pubmed: 20006797
Arch Intern Med. 2009 Dec 14;169(22):2116-23
pubmed: 20008696
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):650-5
pubmed: 23703482
Ann Intern Med. 2012 Oct 2;157(7):471-81
pubmed: 23027318

Auteurs

Bjørn O Eriksen (BO)

Metabolic and Renal Research Group, University of Tromsø - The Arctic University of Norway, Tromsø, Norway bjorn.odvar.eriksen@unn.no.
Section of Nephrology, Clinic of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.

Runolfur Palsson (R)

Division of Nephrology, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
University of Iceland, Reykjavik, Iceland.

Natalie Ebert (N)

Institute of Public Health, Charité - Berlin University of Medicine, Berlin, Germany.

Toralf Melsom (T)

Metabolic and Renal Research Group, University of Tromsø - The Arctic University of Norway, Tromsø, Norway.
Section of Nephrology, Clinic of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.

Markus van der Giet (M)

Department of Nephrology, Charité - Berlin University of Medicine, Berlin, Germany.

Vilmundur Gudnason (V)

University of Iceland, Reykjavik, Iceland.
Icelandic Heart Association, Kopavogur, Iceland.

Olafur S Indridason (OS)

Division of Nephrology, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.

Lesley A Inker (LA)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.

Trond G Jenssen (TG)

Metabolic and Renal Research Group, University of Tromsø - The Arctic University of Norway, Tromsø, Norway.
Department of Organ Transplantation, Oslo University Hospital and University of Oslo, Oslo, Norway.

Andrew S Levey (AS)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.

Marit D Solbu (MD)

Metabolic and Renal Research Group, University of Tromsø - The Arctic University of Norway, Tromsø, Norway.
Section of Nephrology, Clinic of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.

Hocine Tighiouart (H)

Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.
Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts.

Elke Schaeffner (E)

Institute of Public Health, Charité - Berlin University of Medicine, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH